Fisher Inventory vs Other Assets Analysis
FPH Stock | 33.55 0.13 0.39% |
Fisher Paykel financial indicator trend analysis is much more than just examining Fisher Paykel Healthcare latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Fisher Paykel Healthcare is a good investment. Please check the relationship between Fisher Paykel Inventory and its Other Assets accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fisher Paykel Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Inventory vs Other Assets
Inventory vs Other Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Fisher Paykel Healthcare Inventory account and Other Assets. At this time, the significance of the direction appears to have very week relationship.
The correlation between Fisher Paykel's Inventory and Other Assets is 0.28. Overlapping area represents the amount of variation of Inventory that can explain the historical movement of Other Assets in the same time period over historical financial statements of Fisher Paykel Healthcare, assuming nothing else is changed. The correlation between historical values of Fisher Paykel's Inventory and Other Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Inventory of Fisher Paykel Healthcare are associated (or correlated) with its Other Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Assets has no effect on the direction of Inventory i.e., Fisher Paykel's Inventory and Other Assets go up and down completely randomly.
Correlation Coefficient | 0.28 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Inventory
Other Assets
Most indicators from Fisher Paykel's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Fisher Paykel Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fisher Paykel Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Fisher Paykel's Discontinued Operations is comparatively stable compared to the past year. Selling General Administrative is likely to gain to about 517.4 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 2.8 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 938.7M | 885.3M | 1.0B | 1.1B | Total Revenue | 1.5B | 1.5B | 1.7B | 1.8B |
Fisher Paykel fundamental ratios Correlations
Click cells to compare fundamentals
Fisher Paykel Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Fisher Paykel fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.4B | 1.9B | 2.0B | 2.1B | 2.3B | 2.4B | |
Other Current Liab | 133.4M | 178.9M | 181.1M | 219.3M | 256.4M | 269.2M | |
Total Current Liabilities | 324.1M | 393.1M | 281.5M | 271.2M | 385M | 404.3M | |
Total Stockholder Equity | 943.2M | 1.4B | 1.6B | 1.6B | 1.8B | 1.8B | |
Other Liab | 81M | 33.9M | 36.1M | 36.8M | 42.3M | 32.8M | |
Net Tangible Assets | 899.9M | 1.4B | 1.6B | 1.7B | 1.9B | 2.0B | |
Accounts Payable | 67.1M | 52.1M | 53.8M | 43M | 32.4M | 30.0M | |
Cash | 65.0M | 89.5M | 83.3M | 113.3M | 82M | 86.1M | |
Long Term Debt | 22M | 62.8M | 63M | 79.1M | 35.7M | 44.5M | |
Net Receivables | 216.3M | 210.5M | 142.8M | 179.6M | 257.2M | 270.1M | |
Inventory | 141.9M | 248.8M | 332.4M | 342.4M | 320.4M | 336.4M | |
Other Current Assets | 4.0M | 39.4M | 30.7M | 107.3M | 45.3M | 25.6M | |
Total Liab | 446.7M | 509.5M | 395.8M | 422.2M | 522.6M | 548.7M | |
Short Long Term Debt | 80.6M | 11.9M | 5.3M | 4.2M | 78.5M | 82.4M | |
Total Current Assets | 502.4M | 846.0M | 822.4M | 724.6M | 704.9M | 740.1M | |
Short Term Debt | 89.3M | 24.5M | 17M | 21.3M | 96.2M | 101.0M | |
Property Plant Equipment | 735.3M | 882.1M | 957.8M | 1.1B | 1.3B | 1.4B | |
Short Long Term Debt Total | 133.3M | 116.3M | 96.6M | 136.5M | 189.1M | 198.6M | |
Property Plant And Equipment Net | 712.2M | 811.1M | 887.2M | 1.1B | 1.3B | 1.4B | |
Current Deferred Revenue | 34.3M | 137.6M | 29.5M | 6.2M | 7.1M | 6.7M | |
Net Debt | 66.9M | 19.4M | 13.3M | 23.2M | 107.1M | 112.5M | |
Non Current Assets Total | 887.6M | 1.1B | 1.1B | 1.3B | 1.6B | 1.7B | |
Cash And Short Term Investments | 140.3M | 347.2M | 268.5M | 113.3M | 82M | 79.7M | |
Common Stock Total Equity | 198.4M | 219.2M | 225.4M | 249.1M | 286.5M | 156.1M | |
Liabilities And Stockholders Equity | 1.4B | 1.9B | 2.0B | 2.1B | 2.3B | 2.4B | |
Non Current Liabilities Total | 122.6M | 116.4M | 114.3M | 151.0M | 137.6M | 79.8M | |
Property Plant And Equipment Gross | 735.3M | 882.1M | 1.4B | 1.6B | 1.9B | 2.0B | |
Common Stock | 221.8M | 231.1M | 246.7M | 287.3M | 404M | 424.2M | |
Retained Earnings | 664.8M | 946.4M | 1.1B | 1.1B | 1.1B | 1.1B | |
Other Stockholder Equity | (3.5M) | (2.0M) | (123.8M) | (112.3M) | (101.0M) | (96.0M) | |
Accumulated Other Comprehensive Income | 60.2M | 223.1M | 219.8M | 233.2M | 260.1M | 273.1M | |
Intangible Assets | 71.6M | 73.6M | 80.4M | 80.1M | 88.4M | 92.8M | |
Short Term Investments | 75.3M | 257.7M | 185.3M | 500K | 575K | 546.3K | |
Long Term Debt Total | 52.5M | 69M | 44M | 91.8M | 105.6M | 63.1M | |
Treasury Stock | (3M) | (1.8M) | (3.6M) | (2.2M) | (2.0M) | (2.1M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fisher Stock Analysis
When running Fisher Paykel's price analysis, check to measure Fisher Paykel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fisher Paykel is operating at the current time. Most of Fisher Paykel's value examination focuses on studying past and present price action to predict the probability of Fisher Paykel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fisher Paykel's price. Additionally, you may evaluate how the addition of Fisher Paykel to your portfolios can decrease your overall portfolio volatility.